SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Sun Pharma Advanced Research Company
BSE: 532872|NSE: SPARC|ISIN: INE232I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 30, 16:30
328.40
-20.75 (-5.94%)
VOLUME 1,745,650
LIVE
NSE
Jan 30, 16:30
328.10
-21.2 (-6.07%)
VOLUME 5,046,397
Announcements on Sun Pharma Adv

30th-Jan-2015 14:26Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 31-Dec-2014.

22nd-Jan-2015 12:16Source: BSE

Sun Pharma Adv- Shareholding Pattern For December 31, 2014

Sun Pharma Advanced Research Company Ltd has informed BSE about the Shareholding Pattern as on December 31, 2014.

20th-Jan-2015 14:18Source: NSE

Sun Pharma Advanced Research Company Limited

Spurt in Volume : Substantial increase in trading volumes have been observed in Sun Pharma Advanced Research Company Limited.. The Exchange, in order to ensure that investors have latest relevant info...

20th-Jan-2015 13:52Source: BSE

Sun Pharma Adv- Clarification

With reference to Increase in Volume, Sun Pharma Advanced Research Company Ltd has Clarified to BSE as under:

"there is no event which will have a bearing on the performance / operations of the...

16th-Jan-2015 13:06Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange that window closure for Trading by Designated persons as per Insider Trading Rules of the Company will be from January 20, 2015 t...

16th-Jan-2015 12:09Source: BSE

Sun Pharma Adv- Q3 results on Jan 30, 2015

Sun Pharma Advanced Research Company Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 30, 2015, inter alia, to consider and take on record the Un-au...

2nd-Dec-2014 08:34Source: BSE

Sun Pharma Adv- SPARC receives Complete Response Letter (CRL) from USFDA for Latanoprost NDA

Sun Pharma Advanced Research Company Ltd has submitted to BSE a copy of Press Release dated December 01, 2014 titled "SPARC receives Complete Response Letter (CRL) from USFDA for Latanoprost NDA"

2nd-Dec-2014 08:24Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding press release titled "SPARC receives Complete Response Letter (CRL) from USFDA for Latanoprost NDA".

26th-Nov-2014 19:04Source: BSE

Sun Pharma Adv- Conversion of further 5710 partly paid shares of the Company into fully paid shares

Sun Pharma Advanced Research Company Ltd has informed BSE that the Company has further convened 5710 partly paid equity shares into fully paid up equity shares, allotted pursuant to the Rights Issue, ...

1 2 3 4 5 Next >>
Quick Links for Sun Pharma Advanced Research Company
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.